Harilalith Reddy Kovvuri

Dr. Harilalith Reddy Kovvuri

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2026 in Genes
Verified
Journal Article
Open access
PDF file
VBVinod Kumar Balakrishnan
Vinod Kumar Balakrishnan
ARAbinayaa Rajkumar
Abinayaa Rajkumar
MGMonisha K. G. Ganesh
Monisha K. G. Ganesh
HKHarilalith Reddy Kovvuri
Harilalith Reddy Kovvuri
DSDurgadevi Selvam
Durgadevi Selvam
SNSoorappan Rajasekaran Namakkal
Soorappan Rajasekaran Namakkal
Heart failure (HF) is a significant global health challenge, with rising prevalence and a complex, multifactorial pathophysiology. Emerging evidence suggests that disruptions in redox signaling pathways and genetic mutations play critical, synergistic roles in the development and progression of HF. This comprehensive review synthesizes current knowledge on how redox imbalance and genetic alterations interact to drive cardiac dysfunction and critically evaluates the therapeutic strategies targeting these mechanisms. We begin by introducing the basic concepts of redox biology and its role in maintaining cardiac homeostasis. Next, we examine the specific redox signaling pathways and genetic mutations implicated in HF pathogenesis, highlighting the latest mechanistic insights and findings from human studies. The complex interplay between redox dysregulation and genetic factors is explored, including their synergistic effects, compensatory mechanisms, and illustrative case studies. We also review current therapeutic strategies aimed at restoring redox balance and correcting underlying genetic mutations, discussing their progress and limitations. Finally, we present the latest research advances, identify critical knowledge gaps, and propose future directions for both basic and translational research. Understanding the redox–genetic axis is key to developing novel, targeted therapies to address the growing HF epidemic.

8 May 2025 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
NSNagendra Boopathy Senguttuvan
Nagendra Boopathy Senguttuvan
HKHarilalith Reddy Kovvuri
Harilalith Reddy Kovvuri
AGAkshay Prashanth G
Akshay Prashanth G
SSSadhanandham Shanmugasundaram
Sadhanandham Shanmugasundaram
ANAdhiya N.S.S
Adhiya N.S.S
RSRamesh Sankaran
Ramesh Sankaran

24 September 2026 in Indian Heart Journal
Verified
Journal Article
Open access
HKHarilalith Reddy Kovvuri
Harilalith Reddy Kovvuri
JAJudah Nijas Arul
Judah Nijas Arul
HSHarsimran Singh
Harsimran Singh
VKVasudha Krishnan
Vasudha Krishnan
PKPavitraa Saravana Kumar
Pavitraa Saravana Kumar
NSNagendra Boopathy Senguttuvan
Nagendra Boopathy Senguttuvan
While pressure-wire based fractional flow reserve (FFR) is considered the gold standard for evaluating coronary lesion significance, its use in daily clinical practice remains limited.Angiography derived vessel based FFR (vFFR) offers a promising alternative, without the need for pressure wires or hyperaemia by leveraging three dimensional quantitative coronary angiography. This study evaluated the concordance between angiography derived vFFR and invasive FFR in patients with intermediate coronary stenosis. Retrospectively, coronary angiograms of patients who underwent adenosine based FFR from January 2022 until January 2025 for borderline lesions were retrieved from the health management information system (HMIS) software and processed by a blinded core laboratory for vFFR computation. Correlation and diagnostic performance were assessed using Mann-Whitney U testing, Spearman correlation, Bland-Altman analysis, chi-square analysis, ROC curves, and binary logistic regression. The median age of the cohort was 61 years, and 30.6% were female. LAD was the most commonly assessed artery. The median FFR and vFFR values were 0.85 and 0.83, respectively. Overall, 33.9% of lesions were classified as ischemic by FFR. A strong correlation was found between vFFR and invasive FFR (r = 0.808, p < 0.001). The diagnostic performance of vFFR was excellent with an AUC of 0.92. At a vFFR cut off of 0.80, sensitivity was 85.7% and specificity 80.5% with a diagnostic accuracy of 82.3%. Subgroup analysis demonstrated reduced correlations in bifurcation (r = 0.661) and calcified lesions (r = 0.733). In this retrospective cohort, angiography derived vFFR demonstrated good correlation and diagnostic performance compared with invasive FFR for the assessment of intermediate coronary lesions.

7 July 2026 in JACC: Asia
Verified
Journal Article
Open access
NSNagendra Boopathy Senguttuvan
Nagendra Boopathy Senguttuvan
JAJudah Nijas Arul
Judah Nijas Arul
HKHarilalith Reddy Kovvuri
Harilalith Reddy Kovvuri